Jorge Lascano, MD

Jorge Lascano, MD

Jorge Lascano, MD
Professor of Medicine
Assistant Director of Adult Cystic Fibrosis Program

TEL: 352-273-8737





MDUniversidad CaTolica, Ecuador Medicine
ResidencyUniversity of Miami, Jackson Memorial HospitalInternal Medicine
FellowshipUniversity of Miami, Jackson Memorial HospitalPulmonary Disease & Critical Care

Clinical Interests:

  • Cystic Fibrosis
  • Alpha 1 Antitrypsin
  • Non-CF Bronchiectasis
  • Non Tuberculous Mycobacterial Lung Disease

Positions and Honors:

  • Associate Professor of Medicine; Division of Pulmonary and Critical Care, Department of Medicine, University of Florida
  • Director of Adult Cystic Fibrosis Center
  • Co-Director of Respiratory System Course
  • Director of Pulmonary and Critical Care Electives for Students and Residents
  • Director of Education for the Pulmonary and Critical Care Division
  • Core Faculty member for the Internal Medicine Program
  • Member of the Department of Medicine Education Committee
  • Department of Medicine: 2015 Junior Mentor Award
  • Exemplary Teacher Award: 2011, 2012, 2013, 2014, 2015, 2016, 2017


  • Ayoub F, Trillo-Alvarez C, Morelli G, Lascano JRisk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease. World J Hepatol. 2018 Jan 27; 10(1):34-40
  • Ayoub F, Lascano J, Morelli G.  Proton Pump Inhibitor Use Is Associated with an Increased Frequency of Hospitalization in Patients with Cystic Fibrosis. Gastroenterology Res. 2017 Oct; 10(5):288-293.
  • McCorry E, Basher H, Lascano J, Leey J. Clinical Characteristics and Early Treatment Patterns of Newly Diagnosed Cystic Fibrosis–Related Diabetes in Two Tertiary Centers. Diabetes 2018 May; 67(Supplement 1):2374.
  • Lascano J, Shaddoick R, Klinker K, Trillo-Alvarez C.Effect of Therapeutic Drug Monitoring on Clinical Outcomes in Patients with Cystic Fibrosis. NFCFC 2019: A1437
  • Benninger L, Lee J, Krotova K, West J, Lascano J, Brantly MNicotine Plays a Key Role on Inflammation Driven by Monocyte-Derived Macrophages of Subjects with Alpha-1 antitrypsin Deficiency. American Journal of Respiratory and Critical Care Medicine. 2019: A7431
  • Lascano J, Campos M. Neutrophil Chemotaxis Induced by Molecular Modifications of Alpha-1 Antitrypsin (AAT) In COPD Subjects with and Without AAT Deficiency.  American Journal of Respiratory and Critical Care Medicine.  183; 2011: A2429.
  • Lascano J, Campos M. Regulation and Anti-elastase Activity of Locally Produced Alpha-1 Antitrypsin by Well-Differentiated Normal Airway Epithelial Cells: A Comparison with SLPI.   American Journal of Respiratory and Critical Care Medicine.  181; 2010: A4158
  • Lascano J, Brantly M. Effect of Cigarette smoking on Monocyte-Derived-Macrophages of Subjects with Alpha-1 Antitrypsin Deficiency. American Journal of Respiratory and Critical Care Medicine. 191; 2015: A3883
  • Chertoff J, Lascano J.Prognostic utility of plasma lactate measured between 24 and 48h after initiation of early goal-directed therapy in the management of sepsis, severe sepsis and septic shock. Journal of Intensive Care. 2016 Feb 12; 4:13.
  • Chertoff J, Lascano J. Lactate kinetics in sepsis and septic shock: a review of the literature and rationale for further research. Journal of intensive Care. 2015 Oct 6; 3:39